112 related articles for article (PubMed ID: 23302330)
1. [Conceptual issues and diagnostic updates on endometrial serous carcinoma and its precursor].
Zhang TG; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):724-6. PubMed ID: 23302330
[No Abstract] [Full Text] [Related]
2. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
3. Stromal p16 expression is significantly increased in endometrial carcinoma.
Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
[TBL] [Abstract][Full Text] [Related]
4. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
Trahan S; Têtu B; Raymond PE
Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of endometrial cancer: clinicopathologic implications].
Hui P
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):705-7. PubMed ID: 17374250
[No Abstract] [Full Text] [Related]
6. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 expression in endometrial serous carcinomas and its precancers.
Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
[TBL] [Abstract][Full Text] [Related]
8. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
Zhang X; Liang SX; Jia L; Chen N; Fadare O; Schwartz PE; Kong B; Zheng W
Am J Pathol; 2009 Jun; 174(6):2000-6. PubMed ID: 19435786
[TBL] [Abstract][Full Text] [Related]
10. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
[TBL] [Abstract][Full Text] [Related]
11. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
12. [Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
Wang HJ; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):505-7. PubMed ID: 17980094
[No Abstract] [Full Text] [Related]
13. Immunophenotypic Analysis in Early Müllerian Serous Carcinogenesis.
Nafisi H; Ghorab Z; Ismill N; Dubé V; Plotkin A; Han G; Cesari M; Lu FI; Saad R; Khalifa M; Nofech-Mozes S
Int J Gynecol Pathol; 2015 Sep; 34(5):424-36. PubMed ID: 26107560
[TBL] [Abstract][Full Text] [Related]
14. Serous carcinoma arising in an adenofibroma of the endometrium.
Venkatraman L; Elliott H; Steele EK; McClelland HR; McCluggage WG
Int J Gynecol Pathol; 2003 Apr; 22(2):194-7. PubMed ID: 12649677
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors.
Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS
Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389
[TBL] [Abstract][Full Text] [Related]
16. Endometrial intraepithelial carcinoma: a case report and brief review.
Ram M; Bharadwaj M; Yadav R
Indian J Pathol Microbiol; 2008; 51(4):512-4. PubMed ID: 19008579
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
19. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
Abu Backer FM; Mustapha NR; Othman NH
Anal Quant Cytol Histol; 2011 Oct; 33(5):283-8. PubMed ID: 22611756
[TBL] [Abstract][Full Text] [Related]
20. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma.
Tsuda H; Yamamoto K; Inoue T; Uchiyama I; Umesaki N
Br J Cancer; 2000 Feb; 82(3):675-82. PubMed ID: 10682682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
